SecBot SecBot
SECBOTREPLAY Home › Report › IVVD

IVVD · Invivyd appointed Chairman Marc Elia as CEO, replacing the CFO who had…

Invivyd, Inc. · 8-K filed Sep 1, 2026 at 07:10 ET

At the news

NEUTRALIMPACT 6/10

8-K filed Sep 1, 2026 at 07:10 ET

Invivyd appointed Chairman Marc Elia as CEO, replacing the CFO who had been serving as principal executive officer. The filing also announced top-line data from the VYD2311 Phase 3 DECLARATION and LIBERTY studies is expected around the end of Q3 2026, with the company planning to submit a BLA for either traditional or accelerated approval. This is a routine CEO appointment combined with a near-term binary catalyst from pivotal clinical readouts.

  • Marc Elia appointed CEO effective August 30, 2026; he retains Chairman title.
  • Elia receives $750,000 base salary, 70% target bonus, $500,000 sign-on bonus, and an option for 10,700,000 shares.
  • Top-line data from VYD2311 DECLARATION and LIBERTY studies expected around end of Q3 2026.
  • Company plans to submit a BLA for VYD2311 for either traditional or accelerated approval after data readout.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access